Literature DB >> 32521802

Multimodal Decorations of Mesoporous Silica Nanoparticles for Improved Cancer Therapy.

Sugata Barui1, Valentina Cauda1.   

Abstract

The presence of leaky vasculature and the lack of lymphatic drainage of small structures by the solid tumors formulate nanoparticles as promising delivery vehicles in cancer therapy. In particular, among various nanoparticles, the mesoporous silica nanoparticles (MSN) exhibit numerous outstanding features, including mechanical thermal and chemical stability, huge surface area and ordered porous interior to store different anti-cancer therapeutics with high loading capacity and tunable release mechanisms. Furthermore, one can easily decorate the surface of MSN by attaching ligands for active targeting specifically to the cancer region exploiting overexpressed receptors. The controlled release of drugs to the disease site without any leakage to healthy tissues can be achieved by employing environment responsive gatekeepers for the end-capping of MSN. To achieve precise cancer chemotherapy, the most desired delivery system should possess high loading efficiency, site-specificity and capacity of controlled release. In this review we will focus on multimodal decorations of MSN, which is the most demanding ongoing approach related to MSN application in cancer therapy. Herein, we will report about the recently tried efforts for multimodal modifications of MSN, exploiting both the active targeting and stimuli responsive behavior simultaneously, along with individual targeted delivery and stimuli responsive cancer therapy using MSN.

Entities:  

Keywords:  cancer therapy and diagnosis; mesoporous silica nanoparticles; multimodal decorations; stimuli responsive; targeted and controlled cargo release; tumor targeting

Year:  2020        PMID: 32521802     DOI: 10.3390/pharmaceutics12060527

Source DB:  PubMed          Journal:  Pharmaceutics        ISSN: 1999-4923            Impact factor:   6.321


  9 in total

1.  Functionalized Mesoporous Silica Nanoparticles for Drug-Delivery to Multidrug-Resistant Cancer Cells.

Authors:  Nóra Igaz; Péter Bélteky; Dávid Kovács; Csaba Papp; Andrea Rónavári; Diána Szabó; Attila Gácser; Zoltán Kónya; Mónika Kiricsi
Journal:  Int J Nanomedicine       Date:  2022-07-14

Review 2.  Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?

Authors:  María Vallet-Regí; Ferdi Schüth; Daniel Lozano; Montserrat Colilla; Miguel Manzano
Journal:  Chem Soc Rev       Date:  2022-07-04       Impact factor: 60.615

Review 3.  Promising Therapeutic Strategies for Colorectal Cancer Treatment Based on Nanomaterials.

Authors:  Natalia Krasteva; Milena Georgieva
Journal:  Pharmaceutics       Date:  2022-06-07       Impact factor: 6.525

4.  Nanotechnological engineering of extracellular vesicles for the development of actively targeted hybrid nanodevices.

Authors:  Bianca Dumontel; Francesca Susa; Tania Limongi; Veronica Vighetto; Doriana Debellis; Marta Canta; Valentina Cauda
Journal:  Cell Biosci       Date:  2022-05-14       Impact factor: 9.584

Review 5.  Progress in Mesoporous Silica Nanoparticles as Drug Delivery Agents for Cancer Treatment.

Authors:  Eleen Dayana Mohamed Isa; Haslina Ahmad; Mohd Basyaruddin Abdul Rahman; Martin R Gill
Journal:  Pharmaceutics       Date:  2021-01-24       Impact factor: 6.321

6.  Nanocomposite hyaluronic acid-based hydrogel for the treatment of esophageal fistulas.

Authors:  E Piantanida; I Boškoski; G Quero; C Gallo; Y Zhang; C Fiorillo; V Arena; G Costamagna; S Perretta; L De Cola
Journal:  Mater Today Bio       Date:  2021-03-27

Review 7.  Combining Nanotechnology and Gas Plasma as an Emerging Platform for Cancer Therapy: Mechanism and Therapeutic Implication.

Authors:  Milad Rasouli; Nadia Fallah; Sander Bekeschus
Journal:  Oxid Med Cell Longev       Date:  2021-10-27       Impact factor: 6.543

8.  siRNA delivery using intelligent chitosan-capped mesoporous silica nanoparticles for overcoming multidrug resistance in malignant carcinoma cells.

Authors:  Razieh Heidari; Pegah Khosravian; Seyed Abbas Mirzaei; Fatemeh Elahian
Journal:  Sci Rep       Date:  2021-10-15       Impact factor: 4.379

Review 9.  Targeted Nanotherapeutics for Respiratory Diseases: Cancer, Fibrosis, and Coronavirus.

Authors:  Joydeb Majumder; Tamara Minko
Journal:  Adv Ther (Weinh)       Date:  2020-10-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.